期刊文献+

人肠生长激素工程菌高效表达培养工艺的研究 被引量:2

Studies on Cultural Technology of High Expression of the Recombinant Human Gut Growth Hormone in E.coli BL21
下载PDF
导出
摘要 为了优化含有人肠生长激素 (rh[Gly2 ]GLP 2 )基因的融合表达工程菌 pED h[Gly2 ]GLP 2高效表达的最适培养工艺条件 ,文章通过摇瓶培养研究了包括培养基组成、初始 pH值、接种量、诱导剂 ,诱导剂浓度、诱导时机及诱导后培养时间等因素对蛋白表达量的影响 ,确定了该工程菌表达目的蛋白的最佳条件 ,目的蛋白表达量可达 4 0 %以上 。 To optimize the cultural technology of the Engineering Bacteria pED-PP-h[Gly 2]GLP-2 containing Recombinant Human Gut Growth Hormone rh[Gly 2]GLP-2, Fermentation conditions, which influence the final yield of protein expression, including growth medium, original pH of culture, inoculation ratio, inducer,concentration of inducer lactose and induced time, culture time after induced and so on, were studied in shaking flasks. The results indicated that, with YM-1 medium(10 g/L monosodium glutamate, 15 g/L beef extract, 25 g/L corn extract), original pH 6.6 of culture, 2% inoculation ratio, cultured 4 hours at 37℃, and then induced 8 hours using 5 mmol/L lactose,examined by SDS-PAGE and gel scanning, the expression level of protein was over 40%.
出处 《药物生物技术》 CAS CSCD 2004年第6期368-372,共5页 Pharmaceutical Biotechnology
基金 国家"8 63"科研项目编号为 :2 0 0 2AA2 170 3 1 2 国家自然科学基金科研项目编号为 :3 0 2 70 2 98 江苏省自然科学和社会发展基金资助项目 科研项目编号为 :BK 95 0 92 3 0 9andBG
关键词 工程菌pED-h[Gly^2]GLP-2 重组融合蛋白类 表达条件 Engineering bacterium pED-h[Gly 2]GLP-2, Recombinant fusion proteins, Expression conditions
  • 相关文献

参考文献12

  • 1Daniel J D, Peter E, Sylvia L A, et al. Induction of intestinal epithelial prolification by glucagon-like peptide 2[J]. Proc Natl Acad Sci USA, 1996,93:7911.
  • 2Tsai CH, M Hill, SL Asa, et al. Intestinal growth-promoting properties of glucagon-like peptide 2 in mice[J]. Am J Physiol,1997, 273 (Endocrinol. Metab),36:E77.
  • 3Drucker D J, Shi Q, Crivici A, et al. Regulation of the biological activity of glucagon-like peptide 2 by dipeptidyl peptidase IV[J]. Nat Biotechnol, 1997,15:673.
  • 4Xin M, Lin Y, Jie L, et al. An X-Prolyl dipeptidyl aminopeptidase from lactococcus lactis expression in E.coli and application for removal of N-terminal pro-pro from recombinant proteins[J]. Protein Expression and Purification, 2002,24: 530.
  • 5Hartmann B, Johnsen A H, Orskov C, et al. Structure, measurement, and secretion of human glucagon-like peptide-2[J].Peptides, 2000,21(1):73.
  • 6Prasad R, Alavi K, Schwartz M Z. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion[J]. J Pediatr Surg, 2000,35(2):357.
  • 7Lovshin J, Drucker D J. New frontiers in the biology of GLP-2[J]. Regul Pept, 2000,90(1-3):27.
  • 8Tavakkolizadeh A, Shen R, Abraham P, et al. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis[J]. J Surg Res, 2000,91(1): 77.
  • 9Jasleen J, Shimoda N, Shen E R, et al. Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation[J]. J Surg Res,2000,90(1):13.
  • 10陈正兰,刘景晶,胡卓逸,丁敏.一种新的融合表达载体的构建[J].中国药科大学学报,2000,31(2):143-147. 被引量:3

二级参考文献2

共引文献72

同被引文献30

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部